M Berretta

Summary

Affiliation: Centro di Riferimento Oncologico
Country: Italy

Publications

  1. ncbi request reprint Feasibility of intraperitoneal Trastuzumab treatment in a patient with peritoneal carcinomatosis from gastric cancer
    M Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano, Italy
    Eur Rev Med Pharmacol Sci 18:689-92. 2014
  2. ncbi request reprint Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN Italy, Via Franco Gallini 2, 33081 Aviano PN, Italy
    Anticancer Agents Med Chem 13:1344-53. 2013
  3. ncbi request reprint Colorectal cancer in elderly patients: from best supportive care to cure
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, Via Franco Gallini 2 33081 Aviano PN Italy
    Anticancer Agents Med Chem 13:1332-43. 2013
  4. pmc Elevated serum levels of Chromogranin A in hepatocellular carcinoma
    Antonio Biondi
    Department of General Surgery, Section of General Surgery and Oncology, Vittorio Emanuele Hospital, Via Plebiscito 628 University of Catania, 95123 Catania, Italy
    BMC Surg 12:S7. 2012
  5. pmc Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
    Alessandra Bearz
    Medical Oncology, IRCCS, Aviano, PN, Italy
    BMC Res Notes 5:482. 2012
  6. doi request reprint Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute IRCCS, Aviano PN, Italy
    Anticancer Drugs 24:212-8. 2013
  7. ncbi request reprint Antiblastic treatment, for solid tumors, during pregnancy: a crucial decision
    M Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN, Italy
    Int J Immunopathol Pharmacol 25:1S-19S. 2012
  8. ncbi request reprint Nutrition in oncologic patients during antiblastic treatment
    Massimiliano Berretta
    Department of Medical Oncology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Via Franco Gallini 2, 33081 Aviano PN, Italy
    Front Biosci (Landmark Ed) 18:120-32. 2013
  9. doi request reprint Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, IRCCS, Via Franco Gallini 2, I 33081 Aviano PN, Italy
    Arch Gerontol Geriatr 55:271-5. 2012
  10. ncbi request reprint The role of nutrition in the development of esophageal cancer: what do we know?
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN, Italy
    Front Biosci (Elite Ed) 4:351-7. 2012

Detail Information

Publications39

  1. ncbi request reprint Feasibility of intraperitoneal Trastuzumab treatment in a patient with peritoneal carcinomatosis from gastric cancer
    M Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano, Italy
    Eur Rev Med Pharmacol Sci 18:689-92. 2014
    ..This case report evaluates the feasibility and efficacy of intraperitoneal (IP) trastuzumab administration in gastric cancer (GC) patients with peritoneal carcinomatoses...
  2. ncbi request reprint Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN Italy, Via Franco Gallini 2, 33081 Aviano PN, Italy
    Anticancer Agents Med Chem 13:1344-53. 2013
    ..We, retrospectively, analyzed the safety and efficacy of XELOX regimen in the treatment of elderly patients affected by mCRC...
  3. ncbi request reprint Colorectal cancer in elderly patients: from best supportive care to cure
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, Via Franco Gallini 2 33081 Aviano PN Italy
    Anticancer Agents Med Chem 13:1332-43. 2013
    ..In fact, while fit elderly patients could receive the same therapeutic treatment as the younger counterpart, a palliative approach should be taken in consideration for frail elderly patients and for those with a short life expectancy. ..
  4. pmc Elevated serum levels of Chromogranin A in hepatocellular carcinoma
    Antonio Biondi
    Department of General Surgery, Section of General Surgery and Oncology, Vittorio Emanuele Hospital, Via Plebiscito 628 University of Catania, 95123 Catania, Italy
    BMC Surg 12:S7. 2012
    ..The aim of this work was to investigate the role of serum concentration of chromogranin A in patients with hepatocellular carcinoma at different stages...
  5. pmc Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
    Alessandra Bearz
    Medical Oncology, IRCCS, Aviano, PN, Italy
    BMC Res Notes 5:482. 2012
    ..Although first-line therapy for patients affected by advanced mesothelioma is well established, there is a lack of data regarding the impact of second-line treatment...
  6. doi request reprint Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute IRCCS, Aviano PN, Italy
    Anticancer Drugs 24:212-8. 2013
    ..9%). Most drug-related side effects were low grade and manageable. This retrospective study shows favorable survival data among HIV-u-HCC patients treated with sorafenib together with a reasonable safety profile...
  7. ncbi request reprint Antiblastic treatment, for solid tumors, during pregnancy: a crucial decision
    M Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN, Italy
    Int J Immunopathol Pharmacol 25:1S-19S. 2012
    ..This article reviews the available data regarding the different aspects of the treatment of cancer during pregnancy...
  8. ncbi request reprint Nutrition in oncologic patients during antiblastic treatment
    Massimiliano Berretta
    Department of Medical Oncology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Via Franco Gallini 2, 33081 Aviano PN, Italy
    Front Biosci (Landmark Ed) 18:120-32. 2013
    ..Based on this analysis, several nutritional proposals for cancer patients are suggested and the importance of good nutritional status in candidates for hematopoietic stem cell transplantation is highlighted...
  9. doi request reprint Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, IRCCS, Via Franco Gallini 2, I 33081 Aviano PN, Italy
    Arch Gerontol Geriatr 55:271-5. 2012
    ..No toxic death occurred. Oxaliplatin-based chemotherapy maintains its efficacy, and safety in elderly patients with mCRC and good PS. This regimen should be considered in the treatment of this particular setting of patients...
  10. ncbi request reprint The role of nutrition in the development of esophageal cancer: what do we know?
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN, Italy
    Front Biosci (Elite Ed) 4:351-7. 2012
    ..Here we review the role of nutrition in the etiology of esophageal cancer...
  11. ncbi request reprint The role of diet in gastric cancer: still an open question
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute Aviano Pn Italy
    Front Biosci (Landmark Ed) 17:1640-7. 2012
    ..Here we reviewed the role of nutrition as risk/protective factor in the development of gastric cancer...
  12. pmc Hepatocellular carcinoma in HIV-infected patients: check early, treat hard
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN Italy, Via Franco Gallini 2, 33081 Aviano PN, Italy
    Oncologist 16:1258-69. 2011
    ....
  13. doi request reprint FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study
    Massimiliano Berretta
    Department of Medical Oncology, Centro di Riferimento Oncologico, IRCCS, Via Franco Gallini 2, I 33081 Aviano PN, Italy
    Arch Gerontol Geriatr 52:89-93. 2011
    ..FOLFOX4-regimen maintains its efficacy, and safety ratio in elderly patients with mCRC and good performance status. It would be considered the treatment of choice in the treatment of this particular setting of patients...
  14. ncbi request reprint Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute Centro di Riferimento Oncologico, IRCCS, 33081 Aviano PN, Italy
    Curr HIV Res 8:218-22. 2010
    ..The results were analyzed to evaluate feasibility and activity of FOLFOX4 plus highly active antiretroviral therapy (HAART) in metastatic CRC (mCRC) HIV-seropositive patients...
  15. ncbi request reprint Biomarkers in neuroendocrine tumors
    Massimiliano Berretta
    Department of Medical Oncology, National Cancer Institute Aviano, Aviano, PN, Italy
    Front Biosci (Schol Ed) 2:332-42. 2010
    ....
  16. doi request reprint Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study
    Massimiliano Berretta
    Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
    Onkologie 32:319-24. 2009
    ..Data on colorectal cancer (CRC) in HIV-positive patients are limited. The study objective was to investigate and compare clinical presentation and outcome between HIV-positive and HIV-negative CRC patients...
  17. ncbi request reprint Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
    J Chemother 21:215-8. 2009
    ..The ability to use combined modality interventions in patients with secondary malignancies and immunosuppression requires further study with focus on both tolerance and efficacy...
  18. ncbi request reprint FOLFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, CRO IRCCS, Aviano, Italy
    J Chemother 20:503-8. 2008
    ..9 and 21.8 months, respectively) between middle aged and elderly patients. The FOLFOX2 regimen provides equivalent feasibility, efficacy, and survival gain in middle-aged and in elderly patients with metastatic CRC...
  19. doi request reprint Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer
    Massimiliano Berretta
    Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
    Onkologie 31:394-7. 2008
    ..To date, there is little evidence in the English literature about chemotherapy treatment in HIV-positive patients with metastatic colorectal cancer...
  20. ncbi request reprint Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature
    M Berretta
    Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico, Aviano, Italy
    J Chemother 18:221-4. 2006
    ..Antiangiogenetic agents are of interest for this disease due to the peculiar origin of the cells of these sarcomas...
  21. doi request reprint Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection
    C Simonelli
    Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
    J Med Virol 81:888-96. 2009
    ..Multivariate analysis confirmed the diagnosis of lymphoma as an independent predictor of shorter survival...
  22. ncbi request reprint Cetuximab/targeted chemotherapy in an HIV-positive patient with metastatic colorectal cancer in the HAART era: a case report
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
    J Chemother 19:343-6. 2007
    ..This case suggests that, in the HAART era, a multidisciplinary approach can be offered to HIV patients with advanced cancer when they have good performance status, resulting in efficacious control of the HIV infection...
  23. ncbi request reprint Metastatic angiosarcoma of the spleen. A case report and treatment approach
    M Rupolo
    Divisione di Oncologia Medica, Centro di Riferimento Oncologico, IRCCS, Istituto Nazionale Tumori, Aviano, Italy
    Tumori 87:439-43. 2001
    ....
  24. ncbi request reprint Dysphonia as an unusual toxic event of oxaliplatin-based chemotherapy
    M Berretta
    Division of Medical Oncology A and 3B National Cancer Institute, Aviano, Italy
    J Chemother 16:595-8. 2004
    ..This toxic effect was self-limiting and all patients recovered rapidly. Nonetheless, a deeper understanding of this phenomenon is essential to give correct information to the patients...
  25. ncbi request reprint Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience
    F Martellotta
    Division of Medical Oncology A, National Cancer Institute, Aviano, Pordenone, Italy
    Eur Rev Med Pharmacol Sci 16:1283-91. 2012
    ..Squamous cell carcinoma of the anus (SCCA) is a relatively uncommon cancer. In the HIV-positive patients the introduction of the highly active antiretroviral therapy (HAART) did not change the incidence of SCCA...
  26. ncbi request reprint Lung cancer in HIV positive patients: the GICAT experience
    A Bearz
    Department of Medical Oncology, National Cancer Institute IRCCS, Aviano PN, Italy
    Eur Rev Med Pharmacol Sci 18:500-8. 2014
    ..Our aim was to study the impact of HAART on natural history of lung cancer in HIV-positive patients, comparing patients with HIV-lung cancer treated in the pre-HAART era versus the HAART era...
  27. ncbi request reprint Antiblastic treatment of haematological malignancies during pregnancy: a crucial decision
    M Michieli
    Department of Medical Oncology, National Cancer Institute, Aviano PN, Italy
    Int J Immunopathol Pharmacol 25:21S-32S. 2012
    ..The standard approach in non-pregnant women is illustrated as reference...
  28. ncbi request reprint Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy
    R Di Francia
    National Cancer Institute, Fondazione G Pascale IRCCS, Naples, Italy
    Eur Rev Med Pharmacol Sci 16:1211-7. 2012
    ..However, the efficacy of FluOx-based therapy is often compromised because of the severe risk of toxicity. Stratification of patients for multidrug response is a promising strategy for cancer treatment and personalized therapy...
  29. ncbi request reprint MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma: an experience on 26 patients
    A Bearz
    Division of Medical Oncology A, National Cancer Institute, Aviano, Pordenone, Italy
    Int J Biol Markers 22:307-11. 2007
    ..No tumor marker has been validated in the diagnosis and follow-up of lung cancer, in particular to predict the outcome of treatment with EGFR inhibitors...
  30. ncbi request reprint Occult small cell lung cancer associated with paraneoplastic neurologic syndrome: case report
    A Bearz
    Department of Medial Oncology B, CRO IRCSS, National Cancer Institute, Aviano, Italy
    Tumori 87:447-50. 2001
    ..The course of the small cell lung cancer was very indolent and the paraneoplastic neurologic syndrome did not worsen with the use of cisplatin...
  31. doi request reprint Cancer-related fatigue in the elderly
    A Giacalone
    Medical Oncology Department, National Cancer Institute IRCCS, Via Franco Gallini 2, 33081, Aviano, Pordenone, Italy
    Support Care Cancer 21:2899-911. 2013
    ..Although it has been estimated that up to 70 % of elderly with cancer experience fatigue, this symptom is still largely ignored in ageing population...
  32. ncbi request reprint Treatment of 741 Italian patients with chronic fatigue syndrome
    U Tirelli
    Department of Medical Oncology, Division of Medical Oncology A, National Cancer Institute of Aviano, Pordenone, Italy
    Eur Rev Med Pharmacol Sci 17:2847-52. 2013
    ..4 to 2.5% in the general population. In our prior studies on the clinical features of 205 CFS patients we founded immunological and brain abnormalities. In this paper we illustrate our caseload on CFS treatment...
  33. ncbi request reprint Obstetrical, fetal and postnatal effects of gestational antiblastic chemotherapy: how to counsel cancer patients
    L Del Pup
    Division of Gynecological Oncology, National Cancer Institute, Aviano PN, Italy
    Int J Immunopathol Pharmacol 25:33S-46S. 2012
    ..This article reviews the available data regarding the different aspects of systemic treatment of cancer during pregnancy to help oncologist and obstetricians in counseling their patients and treat them accordingly...
  34. ncbi request reprint Ifosfamide in the adjuvant therapy of soft tissue sarcomas
    S Frustaci
    Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano, General Hospital, Gorizia, Italy
    Oncology 65:80-4. 2003
    ..However, the 5-year overall survival estimate, which is a reasonable end point for the survival analysis of adjuvant treatment in soft tissue sarcomas, was 66.0 and 46.1% for the treatment and the control groups, respectively (p = 0.04)...
  35. ncbi request reprint Treatment of older breast cancer patients with high recurrence risk
    D Crivellari
    Division of Medical Oncology C, Centro di Riferimento Oncologico, 33081, Aviano, Italy
    Crit Rev Oncol Hematol 46:241-6. 2003
    ....
  36. ncbi request reprint Knowledge and skills needs for health professions about pharmacogenomics testing field
    R Di Francia
    Hematology Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Fondazione G Pascale IRCCS, Naples, Italy
    Eur Rev Med Pharmacol Sci 16:781-8. 2012
    ....
  37. pmc Target therapies in lung cancer
    A Bearz
    Department of Medical Oncology, National Cancer Institute, CRO IRCCS, Aviano, Italy
    J Biomed Biotechnol 2011:921231. 2011
    ..The increased specificity should lead to decreased toxicity and better activity. Herein we provide an update of the main target therapies in development or already available for the treatment of nonsmall cell lung cancer...
  38. ncbi request reprint Genetic variants influencing fluoropyrimidine based-therapy and available methods to detect them
    R Di Francia
    Hematology Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Fondazione G Pascale IRCCS, Naples, Italy
    Eur Rev Med Pharmacol Sci 16:285-98. 2012
    ..A multitude of methods has been applied to assess the mutational status of these genes, without defining a golden standard for the daily diagnostic routine, so far...
  39. ncbi request reprint Comorbidity assessment and radiotherapy in elderly cancer patients
    F Fiorica
    Department of Radiation Oncology, University Hospital, Ferrara, Italy
    Eur Rev Med Pharmacol Sci 16:1605-6. 2012
    ..There is a lack of clinical trials to drive evidence-based decision making in the elderly cancer patients. In this review, we address the most important issue surrounding the treatment of older cancer patients: comorbidity assessment...